by Tainted Skin-lightening Creams of Personal Care Brands Show Alarming Health Issues in Individuals
Unique mercury poisoning cases are creating revenue streams for healthcare companies in the mercury poisoning treatment market. For instance, in December 2019, it was reported that a women entered into comatose after using a skin-lightening cream of a world-renowned personal care brand, which was tainted with high levels of mercury. Such cases are increasing the demand for drugs induced with chelating agents and combination therapies in the mercury poisoning treatment market. As such, the market for mercury poisoning treatment is projected to expand at a favorable CAGR of ~5% during the forecast period.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111859
Other key market drivers such as increased level of mercury emissions are fueling the demand for treatments involving combination therapy with chelating agents in the market for mercury poisoning treatment. It has been found that over the past several hundred years, mining and other human activities have released several million tons of mercury in the environment. Researchers at the David Streets of Argonne National Laboratory, U.S., stated that several pollutants, including mercury have not been sequestered naturally, and hence remain mobile in the environment causing new cases of mercury poisoning among individuals.
Reinvestigation of Species Activities Surge in Mercury Poisoning Treatment Market
Researchers are using state-of-the-art methods to reinvestigate the historic Minamata mass mercury poisoning incident. For instance, researchers at the University of Saskatchewan (USask) are using novel techniques to study historic animal brain tissue samples to understand how mercury acts in the environment and affects humans. This is evident since individuals are prone to risks of exposure to mercury by the consumption of shellfish and fish items such as the Japanese delicacy Sushi.
Get a glimpse of the in-depth analysis through our Report Brochure
Activities such as reassessment of species involved in other organic mercury poisoning incidents, such as in Grassy Narrows, Ontario, are surging in the mercury poisoning treatment market. This explains why the revenue of organic mercury poisoning dictates the highest share among all forms in the market for mercury poisoning treatment. The high incidence of impaired peripheral vision and muscle weakness due to mercury exposure are creating revenue opportunities for companies in the market for mercury poisoning treatment.
Mercury-free Alternatives for Dental Fillings Generate Value-grab Opportunities for Practitioners
The high incidences of mercury poisoning are reported due to dental amalgams. These amalgams are traditionally made of a mix of mercury and a metal alloy that contains copper, silver or tin, which are used to fill dental cavities. Hence, scientists in the mercury poisoning treatment market are introducing mercury-free alternatives for fillings in order to reduce incidence of mercury exposure. Such innovative trends are boosting the revenue of the mercury poisoning treatment market, which is estimated to reach a value of ~US$ 50 Mn by the end of 2030.
Companies in the market for mercury poisoning treatment should collaborate with scientists to innovate in mercury-free alternatives for dental fillings. However, these alternative fillings are more expensive than traditional amalgams, which restricts its wide scale adoption in dental care settings. Hence, dental care practitioners in the market for mercury poisoning treatment are gaining efficacy in ultrasound, laser, and drug-based treatments to stimulate the regeneration of dentine.
Constant Contact with Federal Agencies Helps Anticipate Uncertainties amidst COVID-19 Pandemic
Healthcare systems worldwide are prepared to evaluate and care for patients with COVID-19 (coronavirus) or are suspected to contact the novel virus. Since mercury emissions are already prevalent in the environment, hospitals are in daily contact with local, state, and federal agencies in order to stay uncompromised when situation arises to treat patients with mercury poisoning. Hospitals in the market for mercury poisoning treatment are adopting safety practices in situations where patients require emergency care.
Companies in the mercury poisoning treatment market are increasing their production capabilities in drugs such as chelating agents to avoid any shortages in medical supplies. They are placing a skeleton crew to organize these production activities. Manufacturers are increasing the availability of mercury-free alternatives for dental fillings in case of pediatric dental care emergency cases.
Analysts’ Viewpoint
Companies in the mercury poisoning treatment market are increasing the availability of drugs, especially involving chelating agents to meet emergency case requirements of individuals exposed to mercury amidst the COVID-19 outbreak. Researchers are leveraging their reinvestigation activities of historic animal species with the help of spectroscopy and sophisticated computational methods.
Mercury-free alternatives for dental fillings such as composite fillings, glass ionomer fillings, and gold inlays are creating revenue streams for dental practitioners. However, these alternatives are more expensive than traditional dental amalgams. Hence, healthcare companies should increase awareness about drug-based treatments and laser therapies that offset the risks involved with mercury poisoning.
Mercury Poisoning Treatment Market: Overview
The global mercury poisoning treatment market for the historical period (2018–2019) and the forecast period (2020–2030), increase in disorders due to mercury is projected to drive the global mercury poisoning treatment market in the near future
According to the report, the global mercury poisoning treatment market was valued at ~US$ 32 Mn in 2019 and is anticipated to expand at a CAGR of ~5% from 2020 to 2030
Increase in Disorders due to Mercury to Drive Global Market
Human exposure to methylmercury (MeHg) is primarily due to intake of contaminated fish and seafood, which have been exposed to mercury through ingestion of contaminated lower organisms
According to the World Health Organization (WHO), methylmercury is toxic to the peripheral and central nervous systems. Inhaled mercury vapor can have harmful effects on the digestive, nervous, and immune systems, lungs, and kidneys.
The gastrointestinal tract absorbs about 95% of ingested MeHg. It enters the red blood cells and the brain by binding covalently to cysteine protein groups and glutathione.
Neurological conditions such as seizures, memory loss, mental retardation, language disorders, hearing loss, vision, and delayed development are the effects of mercury poisoning. In children, a syndrome characterized by painful and red extremities called acrodynia is caused due to chronic mercury exposure.
Rise in Usage of Dental Amalgams Propels Global Market
Amalgam has been used in dentistry for around 150 years. It is still being used due to low cost, ease of strength, bacteriostatic effect, application, and durability. Primary exposure to mercury from dental amalgam occurs during removal and placement of restoration in the tooth. Symptoms of amalgam allergy include skin rashes in the neck and head area, swollen lips, and itching.
Usage of amalgam is decreasing due to environmental pollution, detrimental health effects, and esthetics. Modern amalgams are made of precapsulated (preproportioned) alloy, including 42% to 45% mercury in weight. This could cause psychological and neurological disorders such as Alzheimer’s disease and Parkinson’s.
According to the WHO, dental amalgam is a significant source of exposure, as it can contain up to 50% elemental mercury. It releases fine particles or ions of mercury, which could be ingested or inhaled. Amalgam could represent an occupational risk for dentists. It could cause release of mercury into the atmosphere during cremation.
Limited Availability of Treatment to Hamper Global Market
Treatment of mercury toxicity i.e., poisoning, is quite limited. Treatments available are DMSA, 2,3-dimercaptosuccinic acid, British anti-lewisite (BAL) or dimercaprol, and dimercaptopropanesulfoxid acid (DMPS). These are currently used as chelating agents in mercury poisoning.
Evaluation of mercury exposure and toxicity is less due to limited laboratory testing
According to the WHO, drugs are utilized in a limited amount. The WHO has set the standards of intake of these drugs.
Mercury poisoning treatment drugs are under clinical trials. For instance, Emeramide is an exceptionally safe antidote for heavy metal poisoning and a powerful antioxidant. It is currently under the European Medical Agency (EMA) and the United States Food and Drug Administration (FDA) drug approval process. The manufacturer of Emeramide is EmeraMed.
Mercury Poisoning Treatment Market: Competition Landscape
This report profiles major players operating in the global mercury poisoning treatment market based on attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global mercury poisoning treatment market is moderately fragmented, with the presence of a few large players in the international market and numerous small players in regional markets. The top players hold major share of the global mercury poisoning treatment market.
Prominent players operating in the global mercury poisoning treatment market include
- Mylan N.V.
- Akorn
- Incorporated
- EmeraMed
- Sanofi,
- Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG
- Genex Pharma
Key Questions Answered in Report on Mercury Poisoning Treatment Market
- What are the major drivers, restraints, and opportunities in the global mercury poisoning treatment market?
- What would be the revenue share projection of key segments of the global mercury poisoning treatment market during the forecast period?
- Which segment is likely to lead the global mercury poisoning treatment market, in terms of revenue, between 2020 and 2030?
- How mergers & acquisitions among players are widening the scope for the global mercury poisoning treatment market?
- What is the market position of different companies operating in the global mercury poisoning treatment market?
Mercury Poisoning Treatment Market – Segmentation
Drug
- Chelating Agents
- Dimercaprol or British anti-Lewisite (BAL)
- Dimercaptosuccinic Acid (DMSA)
- DMPS
- Penicillamine
- Others
- Combination Therapy with Chelating Agents
- Plasma Exchange Hemodialysis Plasmapheresis
Type
- Acute Mercury Poisoning
- Chronic Mercury Poisoning
Treatment Type
- Supportive Treatment
- Antidotal Treatment
- Form
Inorganic Mercury
- Elemental Mercury
- Organic Mercury
Route of Administration
- Injectable
- Oral
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111859/2900
